Neulasta

Generic name: Pegfilgrastim
Drug class: Colony stimulating factors

Usage of Neulasta

Neulasta is a man-made form of a protein that stimulates the growth of white blood cells in your body. White blood cells help your body fight against infection.

Neulasta is a prescription medicine used to prevent Neutropenia (a lack of certain white blood cells) that is caused by receiving chemotherapy.

Neulasta helps reduce the chance of infections.

Neulasta side effects

Get emergency medical help if you have signs of an allergic reaction to Neulasta: hives, skin rash, sweating, warmth or tingly feeling; dizziness, fast heartbeats; wheezing, difficulty breathing; swelling of your face, lips, tongue, or throat.

Capillary leak syndrome is a rare but serious side effect of pegfilgrastim. Call your doctor right away if you have signs of this condition, which may include: decreased urination, tiredness, dizziness or light-headed feeling, trouble breathing, and sudden swelling, puffiness, or feeling of fullness.

Call your doctor at once if you have:

sudden or severe pain in your left upper stomach spreading up to your shoulder;

sudden and severe pain in your chest, stomach, or back;

severe or ongoing pain anywhere in your body;

fever, tiredness;

shortness of breath, rapid breathing;

easy bruising, unusual bleeding, purple or red spots under your skin;

bruising, swelling, or a hard lump where the medicine was injected; or

kidney problems - little or no urination, pink or dark urine, swelling in your face or lower legs.

Your cancer treatments may be delayed or permanently discontinued if you have certain side effects.

Common Neulasta side effects may include:

bone pain; or

pain in your arms or legs.

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.

Before taking Neulasta

You should not use Neulasta if you are allergic to pegfilgrastim or filgrastim (Neupogen).

To make sure this medicine is safe for you, tell your doctor if you have ever had:

sickle cell disorder;

kidney disease;

acute myeloid leukemia;

radiation treatment;

myelodysplasia syndrome (also called "preleukemia"); or

a latex allergy.

Tell your doctor if you are pregnant or breastfeeding.

Relate drugs

How to use Neulasta

Use Neulasta exactly as prescribed by your doctor. Follow all directions on your prescription label and read all medication guides or instruction sheets. This medicine should not be given within 14 days before or 24 hours after you receive chemotherapy.

Neulasta is injected under the skin. A healthcare provider may teach you how to properly use the medication by yourself.

Read and carefully follow any Instructions for Use provided with your medicine. Ask your doctor or pharmacist if you don't understand all instructions.

Your blood may need to be tested often.

Prepare your injection only when you are ready to give it. Do not use if the medicine looks cloudy, has changed colors, or has particles in it. Call your pharmacist for new medicine.

Carefully follow your doctor's instructions when giving Neulasta to a child who weighs less than 99 pounds (45 kilograms). The correct dose for a child this size cannot be accurately measured using the prefilled syringe.

You may need medical tests to help your doctor determine how long to treat you with this medicine.

Store the prefilled syringe in its original package in the refrigerator, protected from light. Do not shake or freeze.

Take the syringe out of the refrigerator and let it reach room temperature for 15 to 30 minutes before injecting your dose. If a syringe has become frozen, thaw it in a refrigerator. Do not use any syringe that has been frozen more than one time.

Do not use a syringe that has been left at room temperature for longer than 48 hours.

The Neulasta Onpro Injector is a special device placed on the skin that delivers your pegfilgrastim dose at a specific time. You will need to wear the device for 27 hours before the dose begins. The timed dose will then be released from the device slowly over a 45-miute period.

Keep Neulasta Onpro refrigerated until you are ready to wear it. Do not use an Onpro device that has been left out of a refrigerator for longer than 12 hours.

While wearing Neulasta Onpro, you or a caregiver will need to check the device to make sure it is working properly.

Each prefilled syringe or Onpro Injector is for one use only. Throw it away after one use, even if there is still medicine left inside.

Use a needle and syringe only once and then place them in a puncture-proof "sharps" container. Follow state or local laws about how to dispose of this container. Keep it out of the reach of children and pets.

Warnings

Before using Neulasta, tell your doctor if you have sickle cell disorder, acute myeloid leukemia, myelodysplasia (also called "preleukemia"), or if you are allergic to latex.

Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.

Do not self-inject Neulasta if you do not fully understand how to give the injection and properly dispose of used needles and syringes.

Neulasta is usually given once per chemotherapy cycle. It should not be given within 14 days before or 24 hours after you receive chemotherapy.

What other drugs will affect Neulasta

Other drugs may interact with pegfilgrastim, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.